Grassedonio Emanuele, Incorvaia Lorena, Guarneri Marco, Guagnini Fabio, Midiri Massimo
Biomedicine Department, Neuroscience and Advance Diagnostics, University of Palermo, Palermo, Italy.
Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy.
Drugs Context. 2024 Mar 14;13. doi: 10.7573/dic.2023-11-2. eCollection 2024.
Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 μmol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. Patients with cancer have an increased risk of post-contrast acute kidney injury not only related to the frequent use of contrast medium for computed tomography scans but also to other factors, including the type of tumour, age, oncological therapies, use of other nephrotoxic agents and dehydration. Preventive strategies were developed and may be applied to different risk profiles. Patients at risk may be detected by recently published risk scores.
造影剂后急性肾损伤定义为在血管内注射造影剂后48 - 72小时内,血清肌酐升高>0.3 mg/dL(或>26.5 μmol/L)或高于基线值1.5倍的一种肾病。癌症患者发生造影剂后急性肾损伤的风险增加,这不仅与计算机断层扫描频繁使用造影剂有关,还与其他因素有关,包括肿瘤类型、年龄、肿瘤治疗、其他肾毒性药物的使用和脱水。已制定了预防策略,可应用于不同的风险状况。有风险的患者可通过最近公布的风险评分来检测。